Two Sigma Advisers
CCRN

Two Sigma Advisers’s Cross Country Healthcare CCRN Stock Holding History

Two Sigma Advisers’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,100
Closed -$187K – 391
2025
Q4 		$187K Sell
23,100
-1,900
-8% -$20.8K ﹤0.01% 2138
2025
Q3 		$355K Sell
25,000
-300
-1% -$3.96K ﹤0.01% 1907
2025
Q2 		$330K Buy
+25,300
New +$348K ﹤0.01% 1919
2022
Q1 		– Sell
-18,100
Closed -$502K – 2754
2021
Q4 		$502K Sell
18,100
-8,600
-32% -$208K ﹤0.01% 1910
2021
Q3 		$567K Sell
26,700
-8,100
-23% -$152K ﹤0.01% 1874
2021
Q2 		$575K Sell
34,800
-14,700
-30% -$224K ﹤0.01% 1884
2021
Q1 		$618K Sell
49,500
-40,137
-45% -$426K ﹤0.01% 1916
2020
Q4 		$795K Sell
89,637
-12,500
-12% -$102K ﹤0.01% 1674
2020
Q3 		$663K Buy
102,137
+6,200
+6% +$39.3K ﹤0.01% 1696
2020
Q2 		$591K Buy
95,937
+19,100
+25% +$117K ﹤0.01% 1816
2020
Q1 		$518K Sell
76,837
-3,100
-4% -$29.4K ﹤0.01% 1793
2019
Q4 		$929K Buy
79,937
+23,900
+43% +$270K ﹤0.01% 1614
2019
Q3 		$577K Buy
56,037
+4,800
+9% +$47.2K ﹤0.01% 1662
2019
Q2 		$481K Buy
51,237
+611
+1% +$4.7K ﹤0.01% 1832
2019
Q1 		$356K Sell
50,626
-25,500
-33% -$219K ﹤0.01% 1931
2018
Q4 		$558K Buy
76,126
+3,700
+5% +$31K ﹤0.01% 1721
2018
Q3 		$632K Buy
72,426
+24,100
+50% +$246K ﹤0.01% 1706
2018
Q2 		$544K Buy
48,326
+24,100
+99% +$287K ﹤0.01% 1882
2018
Q1 		$269K Sell
24,226
-27,400
-53% -$343K ﹤0.01% 2053
2017
Q4 		$659K Sell
51,626
-13,900
-21% -$184K ﹤0.01% 1682
2017
Q3 		$932K Sell
65,526
-4,900
-7% -$61.4K ﹤0.01% 1504
2017
Q2 		$909K Buy
70,426
+2,900
+4% +$37.4K ﹤0.01% 1562
2017
Q1 		$970K Buy
67,526
+2,900
+4% +$42.7K ﹤0.01% 1595
2016
Q4 		$1.01M Buy
64,626
+7,200
+13% +$98.6K ﹤0.01% 1550
2016
Q3 		$676K Sell
57,426
-27,300
-32% -$359K ﹤0.01% 1533
2016
Q2 		$1.18M Buy
84,726
+14,600
+21% +$193K 0.01% 1090
2016
Q1 		$816K Sell
70,126
-6,129
-8% -$77.9K ﹤0.01% 1224
2015
Q4 		$1.25M Buy
76,255
+43,529
+133% +$692K 0.01% 927
2015
Q3 		$446K Buy
32,726
+18,900
+137% +$257K ﹤0.01% 1337
2015
Q2 		$175K Buy
+13,826
New +$157K ﹤0.01% 1768
2014
Q3 		– Sell
-44,426
Closed -$290K – 2359
2014
Q2 		$290K Sell
44,426
-63,400
-59% -$419K ﹤0.01% 2027
2014
Q1 		$870K Sell
107,826
-103,800
-49% -$1.02M 0.01% 1233
2013
Q4 		$2.11M Buy
211,626
+158,400
+298% +$1.1M 0.02% 718
2013
Q3 		$320K Buy
53,226
+20,500
+63% +$117K ﹤0.01% 1664
2013
Q2 		$170K Buy
+32,726
New +$168K ﹤0.01% 2009

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Two Sigma Advisers's CCRN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Cross Country Healthcare (CCRN) in Q1 2026, closing a stake of 23,100 shares — an estimated $187K sold.

Two Sigma Advisers first reported a position in CCRN in Q2 2013 and held it in 35 quarters. The position peaked at $2.11M in Q4 2013. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Two Sigma Advisers reported no remaining Cross Country Healthcare position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 23,100 Cross Country Healthcare shares in Q1 2026, an estimated $187K.
  • Two Sigma Advisers first reported a position in Cross Country Healthcare in Q2 2013 and held it in 35 quarters.
  • Two Sigma Advisers's Cross Country Healthcare position peaked at $2.11M in Q4 2013.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.